Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation.

Amit S Kalgutkar; Deepak K Dalvie; Jiri Aubrecht; Evan B Smith; Stephanie L Coffing; Jennifer R Cheung; Chandra Vage; Mary E Lame; Phoebe Chiang; Kim F McClure

doi:10.1124/dmd.106.013649

Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation.

Identifier:nobleid.org/w1/20260515/2FD841D6

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2FD841D6.svg?ark=w1%2F20260515%2F2FD841D6)](https://nobleid.org/work/w1/20260515/2FD841D6)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation.

Identifier:nobleid.org/w1/20260515/2FD841D6

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2FD841D6.svg?ark=w1%2F20260515%2F2FD841D6)](https://nobleid.org/work/w1/20260515/2FD841D6)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work